Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg) - Algorta, Jaime; Diaz, Maria; de Benito, Raquel; Lefebvre, Marc; Sicard, Eric; Furtado, Milton; Regidor, Pedro Antonio; Ronchi, Celestino (The European journal of contraception & reproductive health care, 2017)
Keywords: acceptability; Bioequivalence; burst effect; comparative bioavailability; contraceptive vaginal ring; ethinylestradiol; Etonogestrel; Pharmacokinetics; Polymers; user satisfaction; Vagina; Spain; Etonogestrel; comparative bioavailability; ethinylestradiol; contraceptive vaginal ring; burst effect; acceptability; user satisfaction